Roberts SK - Search Results

1

D-livering the message: the importance of vitamin D status in chronic liver disease.

Kitson MT, Roberts SK. Kitson MT, et al. Among authors: roberts sk. J Hepatol. 2012 Oct;57(4):897-909. doi: 10.1016/j.jhep.2012.04.033. Epub 2012 May 23. J Hepatol. 2012. PMID: 22634121 Free article. Review.

2

Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.

Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Gordon A, et al. Among authors: roberts sk. J Hepatol. 2005 Jul;43(1):38-44. doi: 10.1016/j.jhep.2005.01.031. Epub 2005 Apr 8. J Hepatol. 2005. PMID: 15876468

3

Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C.

Gordon A, Bailey MJ, Gibson PR, Roberts SK. Gordon A, et al. Among authors: roberts sk. J Gastroenterol Hepatol. 2005 Jun;20(6):825-32. doi: 10.1111/j.1440-1746.2005.03828.x. J Gastroenterol Hepatol. 2005. PMID: 15946128

4

Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease.

Kemp W, Pianko S, Nguyen S, Bailey MJ, Roberts SK. Kemp W, et al. Among authors: roberts sk. J Gastroenterol Hepatol. 2005 Jun;20(6):873-81. doi: 10.1111/j.1440-1746.2005.03844.x. J Gastroenterol Hepatol. 2005. PMID: 15946134

5

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

Gordon A, Hobbs DA, Bowden DS, Bailey MJ, Mitchell J, Francis AJ, Roberts SK. Gordon A, et al. Among authors: roberts sk. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):275-80. doi: 10.1111/j.1440-1746.2006.04138.x. J Gastroenterol Hepatol. 2006. PMID: 16460486 Clinical Trial.

6

Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation.

Roberts SK, Kemp W. Roberts SK, et al. J Gastroenterol Hepatol. 2007 Feb;22(2):191-6. doi: 10.1111/j.1440-1746.2006.04459.x. J Gastroenterol Hepatol. 2007. PMID: 17295870

7

Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C.

Roberts SK, Cooksley G, Dore GJ, Robson R, Shaw D, Berns H, Hill G, Klumpp K, Najera I, Washington C. Roberts SK, et al. Hepatology. 2008 Aug;48(2):398-406. doi: 10.1002/hep.22321. Hepatology. 2008. PMID: 18553458 Clinical Trial.

8

Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.

Roberts SK, Weltman MD, Crawford DH, McCaughan GW, Sievert W, Cheng WS, Rawlinson W, Desmond PV, Marks PS, Yoshihara M, Rizkalla B, Depamphilis JK, Dore GJ; Chariot Study Group. Roberts SK, et al. Hepatology. 2009 Oct;50(4):1045-55. doi: 10.1002/hep.23130. Hepatology. 2009. PMID: 19676125 Clinical Trial.

9

GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.

Berzsenyi MD, Bowden DS, Roberts SK, Revill PA. Berzsenyi MD, et al. Among authors: roberts sk. J Gastroenterol Hepatol. 2009 Aug;24(8):1407-10. doi: 10.1111/j.1440-1746.2009.05920.x. J Gastroenterol Hepatol. 2009. PMID: 19702909

10

Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.

Cheng WS, Roberts SK, McCaughan G, Sievert W, Weltman M, Crawford D, Rawlinson W, Marks PS, Thommes J, Rizkalla B, Yoshihara M, Dore GJ; CHARIOT Study Group. Cheng WS, et al. Among authors: roberts sk. J Hepatol. 2010 Oct;53(4):616-23. doi: 10.1016/j.jhep.2010.04.024. Epub 2010 Jun 16. J Hepatol. 2010. PMID: 20619475 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters